Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats

BMC Pharmacology

Volumn 1, Issue , 2001, Pages

  Vera, Pedro L ^a,b,d   Miranda Sousa, Alejandro ^b,d   Nadelhaft, Irving ^a,b,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d Urology Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOTHANE; OLANZAPINE; RISPERIDONE; URETHAN; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; NEUROLEPTIC AGENT; PIRENZEPINE;

ACTION POTENTIAL; ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLADDER CONTRACTION; BLADDER FUNCTION; BLADDER SPHINCTER; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ELECTROSTIMULATION; FEMALE; HIGH FREQUENCY OSCILLATION; MICTURITION; NONHUMAN; PELVIC NERVE; PREDICTION; RAT; RECORDING; RESIDUAL URINE; URINE INCONTINENCE; URINE VOLUME; UROGENITAL SYSTEM PARAMETERS; ANIMAL; BLADDER; BLOOD PRESSURE; DRUG EFFECT; MUSCLE CONTRACTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; URETHRA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BLOOD PRESSURE; FEMALE; MUSCLE CONTRACTION; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE; URETHRA; URINARY BLADDER;

EID: 0642277946     PISSN: 14712210     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2210-1-4     Document Type: Article

References (50)

1. Yoshimura N, de Groat WC: Neural control of the lower urinary tract. Int. J. Urol. 1997, 4:111-125
2. Fowler CJ, Ed: Neurology of Bladder, Bowel, and Sexual Dysfunction. Boston, Butterworth-Heinemann 1999
3. Lieberman JA: Maximizing clozapine therapy: managing side effects. J. Clin. Psychiatry 1998, 59 (suppl 3):38-43
4. Casey DE: Side effect profiles of new antipsychotic agents, J. Clin. Psychiatry 1996, 57 (suppl 11):40-45
5. Stephenson CME, Pilowsky LS: Psychopharmacology of olanzapine. Br. J. Psychiatry Suppl. 38 1999, 174:52-58
6. Vera PL, Nadelhaft I: Effects of the atypical neuroleptic clozapine on micturition parameters in anesthetized rats. Neurourology and Urodynamics,
7. Vera PL, Nadelhaft I: Clozapine inhibits micturition parameters and the external urethral sphincter during cystometry in anesthetized rats. Brain Research 2001, 901:219-229
8. Park JM, Bloom DA, McGuire EJ: The guarding reflex revisited, British Br. J. Urology 1997, 80:940-945
9. Mahony DT, Laferte RO, Blais DJ: Integral storage and voiding reflexes. Neurophysiologic concept of continence and micturition. Urology 1977, 9:95-106
10. Lin C-C, Bai Y-M, Chen J-Y, Lan T-H: A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr. Scand. 1999, 100:158-161
11. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT: Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996, 14:87-96
12. Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors. Focus on newer generation compounds. Life Sciences 2000, 68:29-39
13. Barnes TRE, McPhillips MA: Critical analysis and comparison of the side-effect and safety profiles of the new antipsychotics. Br. J. Psychiatry 1999, 174 (suppl 38):34-43
14. Vernon L, Fuller M, Hattab H, Varnes K: Olanzapine-induced urinary incontinence: treatment with ephedrine. J. Clin. Psychiatry 2000, 61:601-602
15. Fuller MA, Borovickya MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE: Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J. Clin. Psychiatry 1996, 57:514-518
16. Leysen J, Janssen P, Megens A, Schotte A: A novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacological activity. J. Clin. Psychiatry 1994, 55 [5, suppl]:5-12
17. Agarwal V: Urinary incontinence with risperidone. J. Clin. Psychiat. 2000, 61:219
18. Vokas C, Steele V, Norris J, Vernon L, Brescan D: Incidence of risperidone induced incontinence. Schizophrenia Research 1997, 24:267
19. Madhusoodanan S, Brenner R: Risperidone-induced ejaculatory and urinary dysfunction. J. Clin. Psychia. 1996, 57:549-550
20. Kimura Y, Sasaki Y, Hamada K, Fukui H, Ukai Y, Yoshikuni Y, Kimura K, Sugaya K, Nishizawa O: Mechanisms of the suppression of the bladder activity by flavoxate. Int. J. Urol. 1996, 3:218-227
21. Theobald RJ Jr: The effect of arylazido aminopropionyl ATP on atropine resistant contractions of the cat urinary bladder. Life Sciences 1983, 2:2479-2484
22. Snaterse M, Welch R: A retrospective, naturalistic review comparing clinical outcomes of in-hospital treatment with risperidone and olanzapine. Clin. Drug Invest. 2000, 20:159-164
23. Tran P, Hamilton S, Kuntz A, Potvin J, Andersen S, Beasley C Jr, Tollefson G: Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J. Clin Psychopharmacology 1997, 17:407-418
24. Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM: Pharmacokinetic and pharmacodynamic profile. Clin. Pharmacokinet. 1999, 37:177-193
25. Aravagiri M, Marder SR: Simultaneous determination of risperidone and 9-hydroxyrisperdone in plasma by liquid chromatography/electrospray tandem mass spectrometry. J. Mass Spectometry 2000, 35:718-724
26. Maggi CA, Giuliani S, Santicioli P, Meli A: Analysis of factors involved in determining urinary bladder voiding cycle in urethan-anesthetized rats. Am. J. Physiol. 1986, 251:R250-R257
27. Kruse MN, Belton WC de Groat AL: Changes in bladder and external urethral sphincter function after spinal cord injury in the rat. Am. J. Physiol. 1993, 264:R1157-R1163
28. Kruse MN, Noto H, Roppolo JR, de Groat WC: Pontine control of the urinary bladder and external urethral sphincter in the rat. Brain Research 1990, 532:182-190
29. Yoshiyama M, deGroat WC, Fraser MO: Influences of external urethral sphincter relaxation induced by alpha-bungarotoxin, a neuromuscular junction blocking agent, on voiding dysfunction in the rat with spinal cord injury. Urology 2000, 55:956-960
30. Takeda H, Yamazaki Y, Akahane M, Igawa Y, Ajisawa Y, Nishizawa O: Role of the beta3-adrenoceptor in urine storage in the rat: comparison between the selective beta3-adrenoceptor agonist, CL316,243, and various smooth muscle relaxants. JPET 2000, 293:939-945
31. Watanabe T, Constantinou CE: Analysis of pressure/flow characteristics in the female rat and their pharmacologic manipulation. Neurourol & Urodyn. 1996, 15:513-527
32. Ishiura Y, Yoshiyama M, Yokoyama O, Namiki M, de Groat WC: Central muscarinic mechanisms regulating voiding in rats. JPET 2001, 297:933-939
33. Chien C, Yu H, Lin T, Chen C: Neural mechanisms of impaired micturition reflex in rats with acute partial bladder outlet obstruction. Neuroscience 2000, 96:221-230
34. Masuda H, Tsujii T, Azuma H, Oshima H: Role of a central muscarinic cholinergic pathway for relaxation of the proximal urethra during the voiding phase in rats. J. Urol. 2001, 165:999-1003
35. Seki S, Igawa Y, Kaidoh K, Ishizuka O, Nishizawa O, Andersson K-E: Role of D1 and D2 receptors in the micturition reflex in conscious rats. Neurourology and Urodynamics 2001, 20:105-113
36. Jeong MS, Lee JG: The role of spinal and peripheral α1 - and α2-adrenoceptors on bladder activity induced by bladder distension in anesthetized rat. BJU Int 2000, 85:925-931
37. Yoshiyama M, Yamamoto T, de Groat WC: Role of spinal α1-adrenergic mechanisms in the control of lower urinary tract in the rat. Brain Research 2000, 882:36-44
38. Hsu J-W, Wang Y-C, Lin C-C, Bai Y-M, Chen J-Y, Chiu H-J, Tsai S-J, Hong C-J: No evidence for association of alpha 1a adrenoceptor gene polymorphism and clozapine-induced urinary incontinence. Neuropsychobiology 2000, 42:62-65
39. Danuser H, Thor KB: Inhibition of central sympathetic and somatic outflow to the lower urinary tract of the cat by the alpha1 adrenergic receptor antagonist prazosin. J. Urol 1995, 153:1308-1312
40. Danuser H, Bemis K, Thor KB: Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat. JPET 1995, 274:820-825
41. Gajewski J, Downey JW, Awad S: Experimental evidence for a central nervous system action in the effect of alpha-adrenergic blockers on the external urethral sphincter. J. Urol. 1984, 133:403-409
42. Lee JZ, Tillig B, Perkash I, Constantinou CE: Effect of α1 adrenoceptor antagonists on the urodynamics of the upper and lower urinary tract of the male rat. Neurourol. & Urodyn. 1998, 17:213-229
43. Espey MJ, Downie JW: Serotonergic modulation of cat bladder function before and after spinal transection, Eur. J. Pharmacol. 1995, 287:173-177
44. Steers WD, Albo M, van Asselt E: Effects of serotonergic agonists on micturition and sexual function in the rat. Drug Dev. Res. 1992, 27:361-375
45. Testa R, Guarnieri L, Poggesi E, Angelico P, Velasco C, Ibba M, Cilia A, Motta G, Riva C, Leonard A: Effect of several 5-hydroxytryptamine1A receptor ligands on the micturition reflex in rat: comparison with WAY 100635. JPET 1999, 290:1258-1269
46. Conley RK, Williams TJ, Ford APDW, Ramage AG: The role of α1-adrenoceptors and 5-HT1A receptors in the control of the micturition reflex in male anesthetized rats. Br. J. Pharmacol 2001, 133:61-72
47. Danuser H, Thor KB: Spinal 5-HT2 receptor-mediated facilitation of pudendal nerve reflexes in the anesthetized cat, Br. J. Pharmacol. 1996, 118:150-154
48. Espey MJ, Du H-J, Downie JW: Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats, Brain Res. 1998, 798:101-108
49. Aravagiri M, Teper Y, Marder SR: Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharmaceutics & Drug Disposition 1999, 20:369-377
50. Heiman G: Basic Statistics for the Behavioural Sciences, 3rd Ed., Boston, Houghton Mifflin Company 2000